PP
EW icon

Pacifica Partners’s Edwards Lifesciences EW Stock Holding History

Pacifica Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-262
Closed -$23.9K – 514
2024
Q2 		$23.9K Buy
+262
New +$23.2K 0.01% 284
2024
Q1 		– Sell
-80
Closed -$5.51K – 526
2023
Q4 		$5.51K Hold
80
– – ﹤0.01% 420
2023
Q3 		$5.78K Hold
80
– – ﹤0.01% 402
2023
Q2 		$7.28K Hold
80
– – ﹤0.01% 334
2023
Q1 		$6.68K Hold
80
– – ﹤0.01% 353
2022
Q4 		$5.89K Buy
+80
New +$6.17K ﹤0.01% 334
2021
Q4 		– Sell
-57
Closed -$7K – 487
2021
Q3 		$7K Hold
57
– – 0.01% 328
2021
Q2 		$6K Buy
+57
New +$5.37K ﹤0.01% 333

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Pacifica Partners's EW Position: Q3 2024 in Review

Pacifica Partners sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 262 shares — an estimated $23.9K sold.

Pacifica Partners first reported a position in EW in Q2 2021 and held it in 8 quarters. The position peaked at $23.9K in Q2 2024. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Pacifica Partners reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Pacifica Partners sold 262 Edwards Lifesciences shares in Q3 2024, an estimated $23.9K.
  • Pacifica Partners first reported a position in Edwards Lifesciences in Q2 2021 and held it in 8 quarters.
  • Pacifica Partners's Edwards Lifesciences position peaked at $23.9K in Q2 2024.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Pacifica Partners's 13F filing for Q3 2024, filed 7 Oct 2024.